Deliverability & Procedure Success

Proven Driver stent design allows for outstanding deliverability with exceptional device success rates across all trials

Endeavor Trials

Device success: Attainment of <50% in-stent residual percent diameter stenosis of the target lesion using only the assigned device.

Endeavor’s key design elements—thinner cobalt alloy struts, open cell design, and thin polymer coating—may contribute to the exceptional procedure success rate and low rate of periprocedural non-Q-wave MI.

TLR Event-Free Survival at 3 years

Endeavor III clinical trial–Endeavor: n = 321, Cypher: n = 113
Endeavor IV clinical trials–Endeavor: n = 740, Taxus: n = 734
p-values are unadjusted for multiple comparisons.



©Medtronic, Inc. 2007